Current position:Home >Product >
2-({[amino(4-amino-1,2,5-oxadiazol-3-yl)methylidene]amino}oxy)-N-(4-nitrophenyl)acetamide
2-({[amino(4-amino-1,2,5-oxadiazol-3-yl)methylidene]amino}oxy)-N-(4-nitrophenyl)acetamide(5486-27-1)
- Name: 2-({[amino(4-amino-1,2,5-oxadiazol-3-yl)methylidene]amino}oxy)-N-(4-nitrophenyl)acetamide
- Synonyms:Flavone, 3,4',5,7-tetrahydroxy-3'-methoxy-, 4'-a-L-rhamnopyranoside (7CI,8CI); Deglucopasternoside;Rhamnopyranoside, isorhamnetin-4', a-L-
- Molecular Formula:C22H22 O11
- Molecular Weight:321.2489
- CAS Registry Number:5486-27-1
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.5486-27-1 4H-1-Benzopyran-4-one,2-[4-[(6-deoxy-a-L-mannopyranosyl)oxy]-3-methoxyphenyl]-3,5,7-trihydroxy-
Assay:99% Appearance:Powder Package:Aluminium Foil Bag or Fluorinated Bottle Storage:normal temperature preservation Transportation:By Air/Sea/Express Application:Organic Synthesis
Min. Order:0
Supplier:HENAN NEW BLUE CHEMICAL CO.,LTD [
China (Mainland)] 
Assessed
SupplierTel:86-371-55170693/55170694
Address:Zhengzhou International Trade New Territory,Jinshui District,Zhengzhou ,China
- Contact Suppliers
Other Product
- 7502-18-3/6-chloro-2,3-dimethyl-7-nitroquinoxaline
- 84837-06-9/Levisticumofficinale, ext.
- 114430-12-5/(2Z)-3-(4-methylphenyl)-2-nitroprop-2-en-1-yl acetate
- 19314-99-9/H-244/45
- 97808-81-6/Ethanaminium, N-(2-aminoethyl)-2-hydroxy-N,N-dimethyl-, N-(hydrogenated tallow acyl) derivs., esters with hydrogenated tallow fatty acids, chlorides
- 15304-18-4/4-[bis(4-hydroxy-3-methoxyphenyl)methylidene]-2-methoxycyclohexa-2,5-dien-1-one - sulfurous acid (1:1)
- 5468-28-0/bis(2-ethylhexyl) benzylidenepropanedioate
- 53472-17-6/6-AMINOQUINOLINE HYDROCHLORIDE
- 5882-47-3/N-butyl-N-(2-{[3-tert-butyl-1-(4-methoxyphenyl)-1H-pyrazol-5-yl]amino}-2-oxoethyl)-3-phenylpropanamide
- 6343-62-0/3-hydroxy-3-methyl-2-phenylbutanehydrazide
- 6485-67-2/D(-)-Phenylglycinamide
- 2900-20-1/N-ALPHA-CARBOBENZOXY-D-2-AMINOBUTANOIC ACID
- 10430-46-3/9-(acetamido)-5-aminobenzo[a]phenoxazin-7-ium chloride
- 97565-06-5/2-[(4-ethoxyphenyl)carbamoyl]benzene-1,3-diyl diacetate
- 401-48-9/2-(2-carbamoylhydrazinylidene)-3-fluoropropanoic acid
- 56714-19-3/2H-1,3-Oxazine-4,6(3H,5H)-dione, 2,2'-(1,2-ethanediylidene)bis[3-cyclohexyl-5,5-di-2-propenyl-(9CI)
- 14529-40-9/CETETH-10
- 173690-16-9/Benzeneethanol, b-[[4-[2-(dimethylamino)ethoxy]phenyl]phenylmethylene]-a-methyl-, 1-acetate
- 5486-27-1/2-({[amino(4-amino-1,2,5-oxadiazol-3-yl)methylidene]amino}oxy)-N-(4-nitrophenyl)acetamide
- 108432-02-6/Benzene,1,1'-(2-isocyanopropylidene)bis[4-ethoxy-
- 97808-87-2/Iron, 4-((2,4-dihydroxy-5-((2-hydroxy-3,5-dinitrophenyl)azo)-3-((4-nitrophenyl)azo)phenyl)azo)-5-hydroxy-2,7-naphthalenedisulfonate sodium complexes
- 29608-20-6/N,2-dimethyl-4-(piperidin-1-ylmethyl)aniline
- 67026-10-2/2-(bis(2-hydroxyethyl)amino)ethanol; 2-naphthalen-1-ylacetic acid
- 3434-46-6/N-[3-(2-amino-6-methyl-4-thioxo-1,4-dihydropyrimidin-5-yl)propyl]-N-phenylbenzamide
- 92722-35-5/N~4~-(3-methylphenyl)pyrimidine-2,4,6-triamine
- 155029-29-1/Hexacosanamide, 23-[(O-3,4-di-O-acetyl-a-L-arabinopyranosyl-(1®2)-O-[O-2,3,4-tri-O-acetyl-a-L-arabinopyranosyl-(1®4)-b-D-xylopyranosyl-(1®3)]-b-D-xylopyranosyl)oxy]-N-[5-(dimethylamino)pentyl]-22-hydroxy-25-methyl-14-oxo-, (22S,23S)- (9CI)
- 147526-57-6/5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylicacid, 7-[[(2Z)-(2-amino-4-thiazolyl)(methoxyimino)acetyl]amino]-3-[[4-(3-carboxy-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-quinolinyl)-1-piperazinyl]methyl]-8-oxo-,(6R,7R)- (9CI)
- 4492-51-7/1-cyclopentyl-N-methyl-methanamine
- 22707-32-0/3-({[(3,4-dichlorophenoxy)acetyl]amino}methyl)-1-[2-(fluorosulfonyl)benzyl]pyridinium
- 644-37-1/5-(nitrosoamino)pyrimidine-2,4(1H,3H)-dione